Insoluble aggregates of the microtubule associated protein, tau are pathological hallmarks of several neurodegenerative diseases, including Alzheimer's disease (AD), called tauopathies. The tau gene (MAPT) is alternatively spliced and the composition of resulting protein isoforms in aggregates is disease specific. Progressive supranuclear palsy (PSP) is characterised by tangles predominantly containing isoforms with four microtubule binding repeat domains (4R-tau) suggesting that changes in isoform-specific mRNA expression play a role the pathogenesis of the disease. This is supported by the genetics of MAPT. In this study, we quantified expression of 3R-and 4R-tau isoforms at both the mRNA and protein levels in the caudate nucleus, a region severely affected by tau pathology. Results from real-time qPCR and a recently developed ELISA showed statistically significant increase in 4R-tau isoforms in PSP samples compared to controls. In addition, we measured soluble and insoluble hyperphosphorylated tau protein fractions in each PSP sample and compared to the corresponding mRNA transcript levels. No strong correlations were observed with either 3R-or 4R-tau. These findings confirmed the increased ratio of 4R-tau:3R-tau isoforms in PSP. However, we did not find a direct quantitative relationship between individual mRNA and protein levels suggesting a more complex regulation of isoform expression at the post-transcriptional level.
Introduction
The MAPT gene, which encodes for tau protein contains three alternatively spliced exons 2, 3 and 10. These give rise to six tau isoforms in adult human brain [9] . Inclusion of the exon 10 leads to the formation of tau protein isoforms with four microtubule binding repeat domains (4R-tau), whereas isoforms with three repeat domains (3R-tau) result from exon 10 exclusion. The isoform composition in brain is developmentally regulated, with only 3R-tau being expressed in foetal brain and roughly similar levels of 3R-and 4R-tau in adult human brain [9] . In the pathological aggregates, the insoluble, fibrillar 3R-and 4R-tau isoform compositions vary distinctively among tauopathies [10, 11] . The neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) contain both hyperphosphorylated 3R-and 4R-tau isoforms, whereas insoluble 4R-tau dominates in PSP, cortical basal degeneration (CBD), and argyrophilic grain disease [11, 12] .
Conversely, Pick bodies, the aggregates in Pick's disease (PiD) contain mainly hyperphosphorylated 3R-tau [11, 13, 14] . 4R-tau transcripts were measured as described previously [26] . Beta-actin, GAPDH, and HPRT were used as endogenous controls (Applied Biosystems). All samples were run in triplicates.
Fluorescence was detected using the Stratagene Mx3000P qPCR system. All samples were analysed using the delta-delta Ct method. 
Data analysis

results
The caudate nucleus in the basal ganglia region is associated with severe tau pathology in PSP brains [27] . In this study, we measured the expression of 3R-and 4R-tau mRNA isoforms and their corresponding protein isoform levels in fifteen PSP cases and neurologically normal controls.
MAPT isoform mRNA
To measure mRNA levels of each MAPT isoform we employed real-time qPCR using
TaqMan chemistry (Applied Biosystems). All transcripts were normalised to the geometric average of three endogenous reference genes and analysed by the delta delta Ct method.
Four-repeat-tau (4R-tau)-transcripts were overexpressed in PSP samples compared to controls with a p-value of 0.02 (Fig. 1a) , while no changes were observed in 3R-tau transcript levels between PSP and control (Fig. 1b) .
Protein
The 3R-and 4R-tau protein levels in clarified homogenised samples were quantified using the isoform specific 3R-and 4R-tau ELISAs as described previously [24] . The amount of immunoreactive tau was expressed as ng of tau per mg of total brain protein. We observed a significant increase (11.5-fold) in 4R-tau levels in the caudate nucleus of PSP brains compared to control brains (p < 0.05) (Fig. 1c) . There was no statistically significant change in 3R-tau levels ( The median 4R/3R-tau isoform ratio for mRNA expression and combined soluble and insoluble protein levels were found to be 3 and 4.2 respectively (Fig. 2c) . The results suggested a similar degree of increases in 4R-tau at both mRNA and protein levels in these samples tested. The same mRNA transcript ratio was previously reported in globus pallidus, another brain region in basal ganglia that is severely affected by tau pathology in PSP cases [22] . 
discussion
In this study, we investigated the mRNA and protein levels of 3R-and 4R-tau isoforms in a cohort of PSP cases and aged-matched control samples. As expected, we showed that both mRNA and proteins levels are This study shows that the overall tau protein levels correspond to the mRNA levels as increases in both tau immunoreactivity and mRNA levels were observed in the caudate nucleus region of PSP brains compared to control brains.
As expected, we also show that the insoluble tau fraction isolated by highspeed centrifugation consists almost exclusively of 4R-tau isoforms. This is the first direct measurement of tau isoforms from the pathological inclusions and confirms the neuropathological and biochemical classification of PSP as a four-repeat tauopathy [10, 11, 31, 32] . In previous studies, we also showed increased pathological 4R-tau burden in regions associated with pathology [24, 27] 4.1. Messenger RNA-protein correlations In particular, a study of 106 genes in yeast cell found that similar mRNA levels could be accompanied by wide range of protein levels with as much as 30-fold differences and vice versa [34] . Furthermore, a recent study of progranulin (GRN) in frontotemporal lobar 
conclusion
To our knowledge, this is the first study in PSP in which the levels of 3R-and 4R-tau isoforms both at the mRNA and protein levels were 
